Clinical Trial

Guided Needle Insertion for Vascular Access

Study acronym: ACCESS 2
Completed
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to determine whether the study device can assist the cannulator with placing two needles during cannulation required to initiate dialysis treatment. Males or females with end-stage kidney disease who are 18 and older and not pregnant or breastfeeding can be included in the study. The main question it aims to answer is: Can the study device guide the cannulator to the arteriovenous fistula (AVF) or arteriovenous graft (AVG) and assist the cannulator with needle insertion into the AVF or AVG for dialysis cannulation?
Protocol Amendment History 1 change
critical Trial completed 2026-05-30
Trial Details
NCT Number NCT07548151
Lead Sponsor X9, Inc.
Conditions End Stage Renal Failure, Hemodialysis, Cannulation
Enrollment 10 participants
Start Date 2026-04-14
Primary Completion 2026-04-30 (estimated)
Study Completion 2026-04-30 (estimated)
Updated on ClinicalTrials.gov 2026-05-29